YZYi Zhang

Yi Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yi Zhang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Bo Xu

    Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, Jiangsu, 215009, China

    1 shared publication
  • Eishin Yaoita

    Department of Structural Pathology, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan

    1 shared publication
  • Fuyan Ding

    Department of Cardio-thoracic Surgery, Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai, China

    1 shared publication
  • H. Fujinaka

    Department of Structural Pathology, Institute of Nephrology, Graduate School of Medical and Dental Sciences, Niigata University, Japan

    1 shared publication
  • J. Ikei

    Department of Structural Pathology, Institute of Nephrology, Graduate School of Medical and Dental Sciences, Niigata University, Japan

    1 shared publication
  • Jian Yang

    Faculty of Intelligent Manufacturing Wuyi University Jiangmen 529020 P. R. China

    1 shared publication

Latest Publications

  • Evaluation of a novel paclitaxel-eluting stent with a bioabsorbable polymeric surface coating in the porcine artery injury model

    by Fuyan Ding, Zhiqian Lu, Rongjiang Zou, Yi Zhang, Qingkui Guo, Suming Li, Jian Yang

    Purpose Drug-eluting stents (DES) are unique in allowing sustained release after a single short intervention. The challenge with DES still remaining is the optimal combination of a biocompatible drug-eluting matrix including an antiproliferative drug. We studied the role of a novel paclitaxel-eluting stent with a bioabsorbable polymer coating in preventing vascular restenosis in the porcine artery injury model. Material and methods Bare metal stents (BMS); polymer-coated-only stents (POLY); and polymer-based paclitaxel-eluting stents (PACL) were randomly implanted in pig femoral arteries. The dose density of paclitaxel was 1 μ g/mm2 with in vitro studies demonstrating a gradual elution over a course of 6 month. Results After 1-, 3- and 6-month follow-up, respectively, the animals underwent angiographic restudy and were terminated for histomorphometrical and histopathological analyses. At 1 month, the PACL group had the lowest histological percent stenosis when compared to the BMS and POLY groups (20 ± 4% vs 39 ± 6% and 41 ± 6%, respectively, P < 0.05). At 3 months, the PACL group still presents the lowest level of histological percent stenosis among the three groups (27 ± 6% vs 50 ± 10% and 46 ± 5%, respectively, P < 0.01). Six months later, the PACL group showed a similar histological percent stenosis as the BMS and POLY groups (44 ± 9% vs 56 ± 11% and 53 ± 9%, respectively, P= 0.145). Conclusions This study shows favourable vascular compatibility and effi cacy for a novel DES to inhibit in-stent neointima formation and preserve lumen area in the porcine artery model.


  • Open Access

    Dietary supplementation with arachidonic acid but not eicosapentaenoic or docosahexaenoic acids alter lipids metabolism in C57BL/6J mice

    by S. Elewa, T. Ikeda, J. Ikei, Y. Zhang, B. Xu, M. Nameta, H. Fujinaka, Y. Yoshida, E. Yaoita, T. Yamamoto

    Dietary supplementation with arachidonic acid but not eicosapentaenoic or docosahexaenoic acids alter lipids metabolism in C57BL/6J mice